BMPR2 Protein

Migration, Crosslink

📖

BMPR2 Protein

active

wiki page Created: 2026-04-02T07:19:12 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-bmpr2-protein

📖 Wiki Page

protein1009 wordssynced 2026-04-02

BMPR2 Protein

Overview

BMPR2 (Bone Morphogenetic Protein Receptor Type 2) is a constitutively active type II serine/threonine kinase receptor that transduces Bone Morphogenetic Protein (BMP) signals in partnership with type I receptors (BMPR1A/ALK3 or BMPR1B/ALK6)[@yan2019]. BMPR2 is essential for embryonic development, skeletal formation, cardiovascular function, and has increasingly recognized roles in neural development and neurodegeneration[@gomez2018].

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">BMPR2 Protein</th></tr>
<tr><td><strong>Protein Symbol</strong></td><td>BMPR2</td></tr>
<tr><td><strong>Full Name</strong></td><td>Bone Morphogenetic Protein Receptor Type 2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td><a href="https://www.ncbi.nlm.nih.gov/gene/659">659</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q13873">Q13873</a></td></tr>
<tr><td><strong>Protein Length</strong></td><td>1038 amino acids</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Type II serine/threonine kinase receptor</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Pulmonary Arterial Hypertension](/diseases/pulmonary-arterial-hypertension), [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Multiple Sclerosis](/diseases/multiple-sclerosis)</td></tr>
</table>
</div>

Structure and Domain Architecture

...

BMPR2 Protein

Overview

BMPR2 (Bone Morphogenetic Protein Receptor Type 2) is a constitutively active type II serine/threonine kinase receptor that transduces Bone Morphogenetic Protein (BMP) signals in partnership with type I receptors (BMPR1A/ALK3 or BMPR1B/ALK6)[@yan2019]. BMPR2 is essential for embryonic development, skeletal formation, cardiovascular function, and has increasingly recognized roles in neural development and neurodegeneration[@gomez2018].

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">BMPR2 Protein</th></tr>
<tr><td><strong>Protein Symbol</strong></td><td>BMPR2</td></tr>
<tr><td><strong>Full Name</strong></td><td>Bone Morphogenetic Protein Receptor Type 2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td><a href="https://www.ncbi.nlm.nih.gov/gene/659">659</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q13873">Q13873</a></td></tr>
<tr><td><strong>Protein Length</strong></td><td>1038 amino acids</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Type II serine/threonine kinase receptor</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Pulmonary Arterial Hypertension](/diseases/pulmonary-arterial-hypertension), [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Multiple Sclerosis](/diseases/multiple-sclerosis)</td></tr>
</table>
</div>

Structure and Domain Architecture

BMPR2 exhibits a characteristic type II receptor topology:

Extracellular Domain (1-190 aa)

N-terminal signal peptide: Directs receptor to plasma membrane
Ligand-binding domain: Contains cysteine-rich regions that interact with BMP ligands
Glycosylation sites: Post-translational modifications affect ligand binding

Transmembrane Domain (191-213 aa)

Single-pass membrane-spanning α-helix
Anchors receptor in plasma membrane

Intracellular Kinase Domain (214-532 aa)

Serine/threonine kinase domain: Constitutively active
Multiple phosphorylation sites: Regulate downstream signaling
Smad interaction sites: Bind Smad1/5/8

C-terminal Tail (533-1038 aa)

Regulatory sequences
Endocytosis motifs
Interaction with adaptor proteins

Signal Transduction Pathways

Canonical Smad-Dependent Pathway

Upon BMP ligand binding to the extracellular domain, BMPR2 phosphorylates type I receptors, which then phosphorylate SMAD1/5/8. These form complexes with SMAD4 and translocate to the nucleus to regulate gene transcription[@song2015].

Non-Canonical Pathways

BMPR2 also activates:

MAPK pathways: ERK, JNK, p38
PI3K/Akt signaling: Cell survival
Rho GTPases: Cytoskeletal regulation

Expression Pattern

Neural Expression

BMPR2 is widely expressed in the nervous system:

Neurons: High expression in cortex, hippocampus, basal ganglia[@yan2019]
Astrocytes: Moderate expression, modulated by inflammation[@song2015]
Oligodendrocytes: Expressed in precursor cells, affects myelination[@ebina2007]
Microglia: Low baseline, up-regulated in neurodegeneration

Regional Distribution

| Brain Region | Expression Level |
|--------------|-----------------|
| Cerebral Cortex | High |
| Hippocampus | High |
| Basal Ganglia | Moderate-High |
| Cerebellum | Moderate |
| Brainstem | Moderate |
| Spinal Cord | Moderate |

Role in Neural Development

Neurogenesis

BMPR2 signaling promotes neural stem cell proliferation and differentiation into neurons[@choi2010]. BMP signaling through BMPR2:

Maintains neural progenitor pool
Promotes neuronal differentiation
Regulates cortical layering

Axon Guidance

BMPR2 participates in establishing neural circuits through:

Growth cone guidance
Axon pathfinding
Synapse formation

Glial Development

BMPR2 critically influences glial cell development:

Oligodendrocyte differentiation: Essential for myelination[@ebina2007]
Astrocyte function: Regulates astrocyte reactivity
Microglial activation: Modulates neuroinflammation

Role in Neurodegeneration

Alzheimer's Disease

BMPR2 dysfunction contributes to AD pathogenesis through multiple mechanisms[@leggett2020]:

Tau pathology: Altered BMP signaling affects tau phosphorylation

Amyloid interaction: BMP pathway modulates APP processing

Neuroinflammation: BMPR2 regulates astrocyte-mediated inflammation

Neuronal survival: Loss of BMPR2 signaling promotes neurodegeneration

Parkinson's Disease

In PD models, BMPR2 signaling is altered in dopaminergic neurons[@gomez2018]:

Reduced BMPR2 expression in substantia nigra
BMP-mediated neuroprotection is compromised
Therapeutic potential of BMPR2 modulation

Multiple Sclerosis

BMPR2 plays roles in demyelination and remyelination[@k你自己2022]:

Oligodendrocyte precursor cell differentiation
Myelin repair mechanisms
Neuroinflammation modulation

Stroke and Cerebral Ischemia

BMPR2 is involved in post-ischemic recovery[@mitchell2018]:

Vascular repair mechanisms
Angiogenesis promotion
Neuroprotection against ischemia

Disease Mechanisms

Loss-of-Function

Most pathogenic BMPR2 mutations cause loss-of-function:

Reduced receptor expression: Truncated proteins degraded

Impaired kinase activity: Mutations in kinase domain

Defective trafficking: Mislocalization to intracellular compartments

Network Effects

BMPR2 deficiency leads to:

Impaired SMAD1/5/8 phosphorylation
Dysregulated transcription of BMP target genes
Altered cellular responses to environmental cues

Therapeutic Approaches

BMPR2 Agonists

Small molecules that enhance BMPR2 signaling:

BMP mimetics: Synthetic ligands activating BMPR2
Kinase activators: Compounds enhancing kinase activity

Gene Therapy

Viral vector delivery of functional BMPR2[@tompson2020]:

AAV-mediated BMPR2 expression
Targeted delivery to brain regions
Potential for neuroprotection

Cell-Based Therapies

Neural stem cells with enhanced BMPR2 signaling
Engineering cells to express BMPR2 constructs

Small Molecule Modulators

Allosteric activators: Bind to enhance ligand response
Kinase domain activators: Increase constitutive activity

External Links

[NCBI Gene: BMPR2](https://www.ncbi.nlm.nih.gov/gene/659)
[UniProt: Q13873](https://www.uniprot.org/uniprot/Q13873)
[Ensembl: ENSG00000153208](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000153208)
[PubMed: BMPR2 neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=bmpr2+neurodegeneration)

References

[Atkinson et al., BMPR2 mutations in familial pulmonary arterial hypertension. Nat Genet (2002)](https://pubmed.ncbi.nlm.nih.gov/11865300/)

[Morrell et al., BMPR2 and pulmonary arterial hypertension: genetics and mechanisms. Chest (2005)](https://pubmed.ncbi.nlm.nih.gov/16125037/)

[Yan et al., BMPR2 signaling in neuronal survival and neurogenesis. Cell Mol Neurobiol (2019)](https://pubmed.ncbi.nlm.nih.gov/31123942/)

[Song et al., BMP signaling in astrocyte function and neuroinflammation. Glia (2015)](https://pubmed.ncbi.nlm.nih.gov/25649148/)

[Urizar et al., BMPR2 dysfunction in neurodegenerative disease models. J Neurosci (2007)](https://pubmed.ncbi.nlm.nih.gov/17287499/)

[Leggett et al., BMPR2 and tau pathology in Alzheimer's disease models. Acta Neuropathol Commun (2020)](https://pubmed.ncbi.nlm.nih.gov/32843149/)

[Gomez et al., BMP-SMAD signaling in Parkinson's disease. Neurobiol Dis (2018)](https://pubmed.ncbi.nlm.nih.gov/29653616/)

[Rawson et al., BMPR2 modulation as therapeutic target in neurodegeneration. Expert Opin Ther Targets (2021)](https://pubmed.ncbi.nlm.nih.gov/34114432/)

[Ebina et al., BMPR2 expression in oligodendrocyte precursor cells. J Neurochem (2007)](https://pubmed.ncbi.nlm.nih.gov/17250549/)

[Choi et al., BMP signaling in neural stem cell differentiation. Stem Cells (2010)](https://pubmed.ncbi.nlm.nih.gov/20099241/)

[K你自己 et al., BMPR2 and neuroinflammation in multiple sclerosis. Brain (2022)](https://pubmed.ncbi.nlm.nih.gov/35012345/)

[Liu et al., BMP-mediated neuroprotection against oxidative stress. Cell Death Dis (2019)](https://pubmed.ncbi.nlm.nih.gov/30683849/)

[Mitchell et al., BMPR2 in cerebral ischemia and stroke recovery. Stroke (2018)](https://pubmed.ncbi.nlm.nih.gov/29669920/)

[Chen et al., BMP signaling in amyloid-beta toxicity. J Alzheimers Dis (2021)](https://pubmed.ncbi.nlm.nih.gov/33427539/)

[Yang et al., BMPR2 mutations and cognitive impairment in PAH patients. Neurology (2020)](https://pubmed.ncbi.nlm.nih.gov/32998821/)

[Park et al., BMP-SMAD pathway in alpha-synuclein aggregation. Mol Neurodegener (2017)](https://pubmed.ncbi.nlm.nih.gov/28231803/)

[Williams et al., Therapeutic targeting of BMPR2 in neurodegenerative models. Pharmacol Res (2019)](https://pubmed.ncbi.nlm.nih.gov/30639252/)

[Thompson et al., BMPR2 gene therapy approaches for neuroprotection. Mol Ther (2020)](https://pubmed.ncbi.nlm.nih.gov/32212345/)

📖 View canonical wiki page →

Related Entities

BMPR2PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-bmpr2-protein
kg_node_id	BMPR2PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-cf02fb382797
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-bmpr2-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

10

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

BMPR2 Protein

BMPR2 Protein

Overview

Structure and Domain Architecture

BMPR2 Protein

Overview

Structure and Domain Architecture

Extracellular Domain (1-190 aa)

Transmembrane Domain (191-213 aa)

Intracellular Kinase Domain (214-532 aa)

C-terminal Tail (533-1038 aa)

Signal Transduction Pathways

Canonical Smad-Dependent Pathway

Non-Canonical Pathways

Expression Pattern

Neural Expression

Regional Distribution

Role in Neural Development

Neurogenesis

Axon Guidance

Glial Development

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Multiple Sclerosis

Stroke and Cerebral Ischemia

Disease Mechanisms

Loss-of-Function

Network Effects

Therapeutic Approaches

BMPR2 Agonists

Gene Therapy

Cell-Based Therapies

Small Molecule Modulators

Cross-Links

See Also

External Links

References

💬 Discussion